BD to Present at Investor Healthcare Conferences
FRANKLIN LAKES, N.J., Nov. 7 -- BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical technology company, announced today that it would present at the following investor healthcare conferences:
Credit Suisse 2007 Healthcare Conference
November 15, 2007 - 1:00 p.m. (ET)
Lazard Capital Markets Fourth Annual Healthcare Conference
November 27, 2007 - 9:00 a.m. (ET)
A live webcast of BD's presentations at these conferences can be accessed from the BD corporate website at www.bd.com/investors. They will be available for replay for a period of seven days.
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.
FCMN Contact: pat-bandy@bd.com
Source: BD (Becton, Dickinson and Company)
CONTACT: Corporate Communications, Colleen T. White, +1-201-847-5369, for BD
Web site: www.bd.com/
